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Dishevelled (Dvl) is a key regulator of Wnt signaling both in the canonical and non-canonical pathways. Here we report the
identiﬁcation of a regulatory domain of ubiquitination (RDU) in the C-terminus of Dvl. Mutations in the RDU resulted in accumulation
of polyubiquitinated forms of Dvl, which were mainly K63 linked. Small interfering RNA-based screening identiﬁed Usp14 as a
mediator of Dvl deubiquitination. Genetic and chemical suppression of Usp14 activity caused an increase in Dvl polyubiquitination
and signiﬁcantly impaired downstream Wnt signaling. These data suggest that Usp14 functions as a positive regulator of the
Wnt signaling pathway. Consistently, tissue microarray analysis of colon cancer revealed a strong correlation between the levels of
Usp14 and b-catenin, which suggests an oncogenic role for Usp14 via enhancement of Wnt/b-catenin signaling.
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INTRODUCTION
The Wnt signaling pathway regulates key developmental pro-
cesses during embryogenesis as well as various homeostatic
mechanisms in adult animals.
1,2 Aberrant activation of Wnt
signaling is observed in diverse human disorders, including
cancer.
3 The canonical Wnt pathway (Wnt/b-catenin pathway)
maintains b-catenin at a level insufﬁcient for transcriptional
activation, through proteolysis successively mediated via (1)
phosphorylation by the destruction complex consisting of Axin,
glycogen synthase kinase 3b, adenomatous polyposis coil and
casein kinase 1, (2) polyubiquitination by SCF
b-TrCP E3 ligase and
(3) proteasomal degradation.
4 Wnt proteins bind to Frizzled (Fzd)
receptor and low-density lipoprotein-related protein 5/6 co-
receptor, followed by translocation of Dishevelled (Dvl) and Axin
from cytoplasm to plasma membrane to form the Wnt/Fzd/LRP/
Dvl/Axin receptor complex, which functions to suppress
cytoplasmic b-catenin levels. The accumulation of b-catenin in
the cytosol drives its movement into the nucleus, where it
activates the expression of various target genes.
4,5
Vertebrates have three Dvl homologs — Dvl1, Dvl2 and Dvl3 —
and they are common downstream mediators of Wnt signaling in
both canonical and non-canonical pathways.
6 In canonical Wnt
signaling, translocation of Dvls to the receptor complex is essential
for phosphorylation of the PPPSP motif in lipoprotein-related
protein 5/6, which functions as an Axin docking site to promote
stabilization of b-catenin.
7,8 In non-canonical Wnt signaling, which
requires neither lipoprotein-related protein 5/6 phosphorylation
nor b-catenin-mediated gene expression, Fzd-bound Wnt
activates Dvls and regulates various downstream effectors,
including Rac, Rho, CaMKII and the PKC pathway.
9
Dvls contain three conserved domains, including DIX (Dvl and
Axin), PDZ (Post Synaptic Density-95, discs-large and Zonula
occludens-1) and DEP (Dvl, Egl-10 and Pleckstrin) domains. The
Dvl and Axin domain is important for canonical Wnt signaling, the
DEP domain for non-canonical and the PDZ domain for both Wnt
signaling pathways.
6 Therefore, it is thought that Dvls can
differentiate the canonical or non-canonical Wnt signaling
pathways in response to various combinations of Wnt/receptor
activation, although detailed molecular mechanisms remain elusive.
Upon binding of Wnt to receptors, extensive phosphorylation,
which is essential for the activation of both canonical and non-
canonical signaling, occurs in the central regions of Dvl containing
the PDZ and DEP domains. Kinases and other factors involved in
this hyperphosphorylation event include casein kinase 1, casein
kinase 2, PAR1, b-arrestin and PP2A.
10 The activity of Dvl is also
negatively regulated through polyubiquitination by factors such as
KLHL12, NEDL1 and inversin, with modiﬁed Dvl being degraded by
the proteasome.
10,11 In addition to the ubiquitin-proteasome
system, lysosomal degradation pathways may also regulate the
stability of Dvl, according to some reports.
12,13 In particular,
ubiquitination of Dvl by the von Hippel–Lindau E3 ligase is thought
to promote its degradation by the autophagy-lysosome system.
14
Most studies on the regulation of Dvl ubiquitination have focused
on the identiﬁcation of E3 ligases. However, it has been recently
shown that CYLD, a deubiquitinating enzyme (DUB), controls Wnt/
b-catenin signaling by disassembling K63-linked polyubiquitin
chains of Dvl,
15 thereby providing another mechanism for the
regulation of Wnt signal transduction.
When we compared the sequences of Dvl proteins across
species, we found that an B40-amino-acid span in the C-terminus
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www.nature.com/oncsisof Dvl is highly conserved among all vertebrates but not present in
Drosophila Dishevelled (Dsh). The function of this region is not
well understood. In this report, we provide evidence that the
C-terminus of Dvl regulates the ubiquitination status of Dvl via
direct binding of K63-linked polyubiquitin chains. Mutation of key
hydrophobic residues in the C-terminus of Dvl resulted in
increased K63-linked ubiquitination of Dvl. These results led us
to hypothesize that the C-terminal domain of Dvl may cooperate
with unknown DUB(s) to control the ubiquitination status of Dvl.
Based on systematic small interfering RNA (siRNA) screening and
biochemical analysis, we identiﬁed Usp14 as a major DUB of Dvl.
Speciﬁcally, Usp14 regulates the ubiquitination of Dvl and its
subsequent phosphorylation, which is essential for activation of
downstream Wnt signaling. We also identiﬁed a strong correlation
between the levels of Usp14 and b-catenin in human colorectal
cancer cells. Our data collectively indicate that Usp14 may have
oncogenic potential via enhancement of Wnt/b-catenin signaling
in colorectal cancer.
RESULTS
Mutations in the C-terminal domain of Dvl enhance K63-linked
polyubiquitination of Dvl
An B40-amino-acid segment in the C-terminus of Dvl is highly
conserved among vertebrates, while being absent in Drosophila
(Supplementary Figures S1a and S1b).
6 This region stabilizes the
interaction between Dvl and Fzd through direct contact with
Fzd.
16 Whereas BLAST searches on this conserved sequence
revealed no signiﬁcantly similar sequence, we found that the
C-terminal domain of Dvl retained hydrophobic patches as well as
several key residues that are similar to those of ubiquitin-
associated domains, in which these residues participate in
ubiquitin recognition (Supplementary Figure S1c). It has been
reported that the sequences of bona ﬁde ubiquitin-associated
domains from Rad23, Ede1, Ddi1 and Dsk2 share no signiﬁcant
overall homology, whereas they form highly similar three-helix
structures, mainly comprising hydrophobic residues.
17
We reasoned that if the C-terminal domain of Dvl behaves as a
ubiquitin-associated-like domain, then deletion of this domain
may affect ubiquitination of Dvl. To test this possibility,
we transiently overexpressed wild-type Dvl (Dvl-WT) and a
C-terminal domain deletion mutant (Dvl-DRDU; RDU stands
for regulatory domain of ubiquitination, see below) in HEK293T
cells and compared their stability and ubiquitination. While
the steady-state levels of Dvl-WT and Dvl-DRDU were compar-
able, the levels of polyubiquitinated forms of Dvl-DRDU
were strikingly elevated over that of wild type (Figure 1a).
As immunoprecipitation was performed under denaturing
conditions (Supplementary Figure S4a; see details in Materials
and methods), increased ubiquitination seemed to occur on Dvl
rather than proteins associated with it.
It has been suggested that the lysine 48-linked ubiquitin chains
are involved in proteasomal degradation, whereas lysine 63-linked
ubiquitin chains usually have roles in non-degradative signaling
pathways.
18,19 Interestingly, increased ubiquitination of Dvl-DRDU
was observed upon expression of ubiquitin with a point mutation
at lysine 48 (Ub-K48R), but not with a point mutation at lysine
63 (Ub-K63R) (Figure 1b). This result suggests that the poly-
ubiquitin chains formed on Dvl-DRDU are assembled mainly
through K63 linkages. As the C-terminal domain of Dvl regulates
Dvl ubiquitination, we dubbed this the ‘RDU’.
To clarify the relationship between the RDU and Dvl ubiquitina-
tion, we examined whether the RDU is a ubiquitin binding
element. The C-terminus of Dvl (Dvl-CT) was tested together with
ubiquitin chains in an in vitro binding assay. Recombinant GST-
Dvl-CT was incubated with monoubiquitin, K48-linked polyubi-
quitin or K63-linked polyubiquitin (Ub2 to Ub7). GST-Dvl-CT
signiﬁcantly bound to K63-linked polyubiquitin (Figure 1c),
whereas mono UB and K48-linked polyubiquitin were not pulled
down with GST-Dvl-CT. Short K63-linked chains with up to four
ubiquitin groups also failed to show Dvl-CT binding in this assay.
Overall, these data suggest that the RDU of Dvl binds to K63-
linked polyubiquitin chains.
We next attempted to identify residues in the RDU element that
are critical for ubiquitin chain binding. Hydrophobic interactions
are typically critical for speciﬁc ubiquitin recognition.
20 We
therefore hypothesized that conserved hydrophobic residues
Val644 and Val667 of the RDU may be important for the proper
conformation of the RDU as well as ubiquitin recognition.
21
Indeed, tandem substitution of these residues to lysine (the Dvl-
VK2 mutation) strongly impaired recognition of K63 polyubiquitin
chains (Figure 1c).
We next introduced the VK2 mutation into full-length Dvl and
tested whether it affects modiﬁcation of the protein by ubiquitin.
As with the RDU deletion, we observed a dramatic stimulation of
Dvl ubiquitination (Figure 1d). A single substitution, V667K, was
sufﬁcient to produce this effect (Figure 1d). The chains observed
are striking in length. These results suggest that increased
ubiquitination of Dvl may be the outcome of a compromised
RDU-ubiquitin interaction. Application of chain-linkage speciﬁc
ubiquitin antibodies further conﬁrmed that the polyubiquitin
chains of these Dvl mutants contained K63 linkages (Figure 1e).
To determine whether deletion of the RDU affects Dvl activity in
Wnt signaling, a TOPFlash reporter assay was performed (see
Materials and methods). Reporter activity was signiﬁcantly
reduced when cells transiently expressed Dvl-DRDU as compared
Figure 1. Mutations in C-terminal domain of Dvl enhance level of K63-linked polyubiquitination. (a) Deletion of the RDU of Dvl increases
polyubiquitination. Plasmids expressing HA-tagged ubiquitin were co-transfected with myc-tagged Dvl-WT, Dvl-DRDU or empty vector into
HEK293T cells. Total cell lysates were subjected to immunoprecipitation with anti-myc antibody, followed by immunoblotting with anti-HA
antibody. a-tubulin is a loading control. (b) Polyubiquitin chains of Dvl-DRDU mainly form through K63 linkages. Experiments were performed
as described in (a) except for the usage of ﬂag-tagged Ub-K48R or Ub-K63R mutants. After immunoprecipitation using anti-myc antibody,
ubiquitinated fractions of Dvl were detected by immunoblotting with anti-ﬂag antibody. (c) C-terminus of Dvl containing the RDU (Dvl-ct)
directly interacts with K63-linked polyubiqutin chains, but not with monoubiquitin or K48-linked polyubiquitin chains. Recombinant GST-Dvl-
ct, GST-Dvl-ct-VK2 or GST alone (empty) were incubated with various ubiquitin species, followed by GST-pull-down, SDS–PAGE and
immunoblotting for Dvl-bound ubiquitin proteins (right, top). Input is 10% of total ubiquitins used in the pull-down assay (left). Coomassie
Brilliant Blue staining of pulled-down GST species is shown in the bottom panels as a control (right, bottom). (d) Point mutations of putative
ubiquitin recognition residues (V644 and V667) in the RDU of Dvl promote polyubiquitination. Flag-tagged K48R ubiquitin was coexpressed
with wild-type Dvl or its mutant variants into HEK293T cells, followed by immunoprecipitation/immunoblotting for detection of
polyubiquitinated forms of Dvl. (e) Polyubiquitin chain of mutant Dvl is preferentially K63-linked. As in (e), but endogenous ubiquitins and
anti-K63-linkage-speciﬁc Ub antibody (Apu3) were used. (f) Dvl-DRDU, Dvl-V667K and Dvl-VK2 had signiﬁcantly reduced reporter activity
compared with wild-type Dvl. Result of the TOPFlash reporter analysis performed in HEK293T cells in triplicates is shown (top). Po0.00002. As
transfection and loading control, total lysates subjected to immunoblotting for Dvl using anti-myc and b-actin antibodies are shown (bottom).
(g) In contrast to wild-type Dvl, which mainly exists in phosphorylated forms, a signiﬁcant fraction of Dvl-DRDU mutant is not phosphorylated.
After transient expression of myc-tagged Dvl-WTand Dvl-DRDU mutants, lysates were collected, incubated with l phosphatase and subjected
to immunoblotting with anti-myc antibody. Band for endogenous levels of phosphorylated c-jun (p-c-jun) was abolished after treatment with
l phosphatase (marked with arrowhead). b-actin was used as a loading control.
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Oncogenesis (2013), 1–11 & 2013 Macmillan Publishers Limitedwith Dvl-WT (Figure 1f), consistent with the ﬁndings of Tauriello
et al.
16 In addition, Dvl-V667K and Dvl-VK2 showed similar reporter
activity as Dvl-DRDU (Figure 1f). Phosphorylation of Dvl is
necessary for the activation of Wnt signaling.
22,23 We reasoned
that the impaired activation of Wnt signaling by Dvl-DRDU
expression could involve abnormal phosphorylation. Incubation
with l phosphatase resulted in faster migration of Dvl-WT but
not Dvl-DRDU, suggesting that Dvl-DRDU is hypophosphorylated
(Figure 1g). Disappearance of phospho-c-jun after incubation
with l phosphatase was used as a positive control for depho-
sphorylation (Figure 1g). In summary, these data indicate that the
RDU of Dvl is essential for the regulation of ubiquitination and
phosphorylation of Dvl, both of which promote the activation of
downstream Wnt signaling.
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As the RDU suppresses ubiquitination of Dvl, we hypothesized
that the RDU may function in cooperation with an unknown DUB.
To identify a DUB that targets the polyubiquitin chains of Dvl, we
selected nine candidate DUBs that included potential interaction
partners of Dvl from the NCBI database and other DUBs showing
impaired Wnt responsiveness upon shRNA-mediated knock-
down.
15 When Usp14 (designated as DUB6 in Figure 2a) was
knocked down by siRNA, strikingly increased Dvl polyubiquitina-
tion was observed on endogenous Dvl2 (Figure 2a). A similar result
was obtained when cells were treated IU1 (Figure 2b), a small
molecule inhibitor of Usp14.
24 These results suggest that Usp14 is
a key mediator of Dvl deubiquitination. Consistent with these
results, overexpression of a catalytically inactive Usp14-C114A
mutant (Usp14-CA), which can act as a dominant negative,
24
resulted in signiﬁcant accumulation of polyubiquitinated Dvl
(Figure 2c). In summary, the steady-state levels of Dvl ubiquitina-
tion are established through a rapid cycle of ubiquitination and
deubiquitination in which Usp14 has a dominant role.
Usp14 is a proteasome-associated DUB known to be activated
by proteasomes.
24 However, the detailed biochemical mechanism
of activation is still undetermined. Through both catalytic and
non-catalytic mechanisms, Usp14 functions as an endogenous
inhibitor of mammalian proteasomes.
24,25 Speciﬁcally, the
Figure 2. Inhibition of Usp14 increases level of polyubiquitinated Dvl. (a) Knockdown of DUB6 (Usp14) increases polyubiquitination of
endogenous Dvl. siRNAs for different DUBs or control siGFP were co-transfected with plasmids expressing ﬂag-tagged Ub-K48R into HEK293T
cells. Total cell lysates were subjected to immunoprecipitation with anti-Dvl2 antibody or control immunoglobulin G, followed by
immunoblotting with anti-ﬂag antibody to detect the ubiquitinated forms of Dvl2. siRNA targeting Usp14 yielded B90% knockdown
efﬁciency. Note that the data for DUB9/Usp36 knockdown are excluded in the ﬁgure due to severe cell death as previously reported.
34 (b)A s
in a, except that cells were also treated with IU1, an inhibitor of Usp14, at 40mM for 2 days. Effect of IU1 on Dvl2 polyubiquitination was
comparable to that of Usp14 knockdown by siRNA. Dvl2 and Usp14 levels were measured, and endogenous b-actin was used as a loading
control. (c) Expression of catalytically inactive Usp14-CA promotes Dvl polyubiquitination. Wild-type and mutant variants of Usp14 were co-
transfected with ﬂag-tagged Ub-K48R into HEK293T cells. Protein samples were analyzed by immunoprecipitation/immunoblotting as
indicated. (d)A si nc, except that Usp14 siRNA was simultaneously introduced along with transient co-expression of Usp14 variants and ﬂag-
Ub-K48R. Ectopic expression of wild-type Usp14 and Usp14-DUBL was sufﬁcient to reverse Dvl2 ubiquitination induced by Usp14 knockdown.
(e) Usp14 is essential for transduction of Wnt signaling. TOPFlash assay was performed in HEK293T cells introduced with either siGFP or
siUsp14. At 2 days post transfection of siRNA and reporter plasmids, Wnt3a CM were treated for 0, 4, 8 and 12h. Data represent average values
of relative TOPFlash over FOPFlash ratios from one representative experiment performed in triplicate. Error bars indicate standard deviations
in triplicate (*Po0.002). (f) The Usp14-CA mutant inhibits reporter activity induced by Dvl, but not b-catenin. Catalytically inactive Usp14-CA
mutant was coexpressed with b-catenin or Dvl, and reporter assays were performed as described in (e)( * Po0.0003). (g) Ubiquitin chain
trimming assay. HEK293T cells under Usp14 siRNA conditions were transfected with Ub-K48R only (left) or Ub-K48R and Dvl-DRDU (right). At 2
days post transfection, cells were treated with Wnt3a CM for 1h and whole-cell lysates were collected. Polyubiquitinated species of
endogenous and transfected Dvl were enriched by immunoprecipitation using anti-Dvl2 (left) and anti-myc antibodies (right), respectively.
Immunoprecipitates were incubated with BSA (marked with ‘-’), recombinant GST-Usp14-WT, or GST-Usp14-CA protein for an additional 1h.
Levels of Dvl ubiquitination were analyzed by SDS–PAGE and immunoblotting with anti-Flag antibody. Levels of GST-Usp14-WT and
GST-Usp14-CA were determined by Coomassie Brilliant Blue staining.
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with subunit Rpn1 in the proteasome regulatory particle (also
called 19S and PA700
26,27). Interestingly, ectopically expressed
Usp14-DUBL behaved as full-length Usp14 in reversing the effect
of Usp14 siRNA on Dvl polyubiquitination, suggesting that the
disassembly of ubiquitin chains on Dvl may be a proteasome-
independent activity of Usp14 (Figure 2d).
As inhibition of Usp14 activity increased Dvl polyubiquitination,
we examined whether knockdown of Usp14 has any effect on
Wnt signaling. Signiﬁcantly induced Wnt reporter activity was
observed in control HEK293T cells 8h after treatment with
Wnt3a-conditioned media (CM), whereas Usp14 knockdown cells
displayed only slightly increased Wnt reporter activity (Figure 2e).
Accordingly, transient overexpression of Usp14-CA reduced Wnt
reporter activity (Supplementary Figure S2a). In contrast, over-
expression of Usp14-WT or Usp14-DUBL had little effect on Wnt
signal output (Supplementary Figure S2a), suggesting that Usp14
is not a limiting component in the Wnt pathway in HEK293T cells.
Increased Wnt reporter activity upon ectopic expression of Dvl,
but not b-catenin, was reduced by expression of Usp14-CA
(Figure 2f). This suggests that regulation of Wnt signaling
by Usp14 is controlled at the level of Dvl, rather than downstream
components such as b-catenin. This ﬁnding is consistent with the
effect of Usp14 on Dvl ubiquitination (Figure 2a). To test direct
deubiquitination of Dvl by Usp14, we performed a ubiquitin
chain trimming assay using immunopuriﬁed Dvl-ubiquitin
conjugates and recombinant Usp14 in a proteasome-free
condition (Figure 2g and Supplementary Figure S2b). HEK293T
cells were treated with Usp14 siRNA to knock down endogenous
Usp14, followed by transient expression of Ub-K48R. After
incubation with Wnt3a CM, whole-cell extracts were collected
and endogenous Dvl proteins enriched by immunoprecipitation.
Incubation of recombinant Usp14-WT with immunoprecipitates
signiﬁcantly reduced the high-molecular weight species
of polyubiquitinated Dvl, whereas catalytically inactive Usp14-
CA had little or no effect (Figure 2g). In a similar assay,
polyubiquitin chains of Dvl-DRDU mutants were hardly suscep-
tible to deubiquitination by Usp14 (Figure 2g), further suggesting
that the RDU domain is essential for Usp14 interaction and
subsequent deubiquitination.
RDU of Dvl is important for interaction with Usp14
To test for an interaction between Usp14 and Dvl, co-immuno-
precipitation assays were performed. HEK293T cells were trans-
fected with Usp14 constructs, and cell extracts were subjected
to immunoprecipitation using anti-Dvl antibody. Neither endo-
genous Usp14, transiently overexpressed Usp14-WT, nor
the Usp14-DUBL mutant co-immunoprecipitated with endogen-
ous Dvl, regardless of the presence of Wnt3a CM (Figure 3a and
Supplementary Figure S3a). This result could potentially be
attributed to the rapid dissociation of Usp14 from Dvl when
deubiquitination events were completed. However, even cataly-
tically inactive Usp14-CA mutant did not co-immunoprecipitate
with Dvl in normal conditions (Figure 3a). Only when cells were
incubated with Wnt3a CM did the Usp14-CA mutant show strong
interaction with endogenous Dvl (Figure 3a and Supplementary
Figure S3a), suggesting that the interaction is stabilized upon
activation of Dvl by Wnt. In a time course experiment, signiﬁcant
interaction between Usp14-CA and Dvl was observed from 30min
to 2h following incubation with Wnt3a CM (Figure 3b). To conﬁrm
the colocalization of endogenous Dvl and Usp14 in the presence
of Wnt3a CM, indirect immunoﬂuorescent analysis using wild-type
murine embryonic ﬁbroblasts (MEFs) was performed. Although
there was no obvious membrane localization of Dvl upon Wnt3a
CM treatment, colocalized ﬂuorescence signals of endogenous Dvl
and Usp14 clearly peaked at 30–45min upon Wnt3a CM treatment
(Supplementary Figure S3b). Therefore, deubiquitination of Dvl by
Usp14 may occur via their transient interaction during Wnt signal
transduction.
To determine whether the RDU and its putative ubiquitin
binding sites are necessary for the interaction between Dvl and
Usp14, a binding assay similar to that in Figures 3a and b was
performed using transiently overexpressed rather than endogen-
ous Dvl. Whereas Dvl-WT strongly interacted with Usp14-CA in the
presence of Wnt3a CM, Dvl-DRDU or Dvl-VK2 displayed no
Figure 3. Dvl transiently interacts with Usp14 in the presence of Wnt3a. (a) Usp14-CA was transiently overexpressed in HEK293T cells in
parallel with an empty vector control. At 2 days post transfection, cells were cultured in Wnt3a CM or control media for 2h. Total cell lysates
were collected, subjected to immunoprecipitation with anti-Dvl2 antibody or control immunoglobulin G, and analyzed by immunoblotting for
Usp14. Dvl2 and Usp14 in total lysates are shown in the bottom panel. (b) Interaction between Dvl and Usp14 occurs at an early time point
after treatment with Wnt3a CM. HEK293T cells were transfected with Usp14-CA. At 2 days post transfection, cells were cultured in Wnt3a CM
for various times as indicated in the ﬁgure followed by immunoprecipitation/immunoblotting. (c) The RDU is necessary for interaction
between Dvl and Usp14. HEK293T cells were transfected with plasmids expressing myc epitope-tagged WT-, DRDU-, or VK2-Dvl, then cultured
in Wnt3a CM for 30min. Interaction was analyzed by immunoprecipitation using anti-myc antibody.
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data suggest that the binding of polyubiquitin chains by
the C-terminal domain of Dvl creates a speciﬁc conformation
necessary for interaction with Usp14 (see below).
Dvl-DRDU displays increased ubiquitination on K444 and K451
To map the sites of enhanced ubiquitin modiﬁcation on Dvl-
DRDU, we performed electron spray ionization-mass spectrometry.
HEK293T cells were co-transfected with myc-Dvl-DRDU and Ub-
K48R plasmids, followed by a two-step immunoprecipitation as
shown in Supplementary Figure S4a. Immunoprecipitated proteins
were resolved by SDS–PAGE and extracted from gel slices above
the myc-Dvl-DRDU band (Figure 4a). We observed ubiquitinated
Dvl when region I, but not region II, (denoted in Figure 4a) was
used in electron spray ionization-mass spectrometry analysis,
which is consistent with the previous ﬁnding that K63-linked
ubiquitinated forms of Dvl are found in the lower molecular
weight region of the gel, just above unmodiﬁed Dvl.
15 Electron
spray ionization-mass spectrometry analysis identiﬁed ﬁve
candidate ubiquitination sites (K50, K285, K387, K444 and K451)
(Figure 4b and Supplementary Figure S4b). K50 was previously
identiﬁed as a principal K63-linked ubiquitination site in CYLD-
deﬁcient cells, and K285 has been assigned as a K48-linked
ubiquitination site.
15 In subsequent experiments, we focused on
K444 and K451, which are highly conserved residues within the
DEP domain. When these and two other highly conserved lysine
residues (413 and 461) in the DEP domain were changed into
arginine, the level of ubiquitinated forms of the Dvl-DRDU mutant
(Dvl-DRDU-DEP4KR) was strongly reduced compared with that of
Dvl-DRDU (Figure 4c). As Dvl-DRDU-DEP4KR was only weakly
ubiquitinated, we reasoned that knockdown of Usp14 might have
little effect on the reporter activity induced by Dvl-DEP4KR.
Indeed, the reporter activity induced by Dvl-WT, but not
Dvl-DEP4KR, was inhibited by knockdown of Usp14 (Figure 4d).
Together, these results strongly suggest that the increased
ubiquitination of Dvl-DRDU upon knockdown of Usp14 occurs
within the DEP domain, particularly on K444 and K451. We then
tested whether the reduced reporter activity in response to Wnt3a
CM in the presence of siUsp14 (Figure 2e) might be due to
blocking of the interaction between Fzd and ubiquitinated Dvl.
Interestingly, Dvl-VK2 did not interact with Fzd5 whereas Dvl-
DEP4KR was comparable with Dvl-WT in its interaction with Fzd5
(Figure 4e). These data suggest that deubiquitination of Dvl by
Usp14 is necessary for the interaction between Fzd and Dvl.
Attenuation of Wnt signal transduction by Usp14 inhibition
To further test whether Usp14 is necessary for Wnt signaling, we
employed MEFs from Usp14
/ mice.
28 Compared with wild type,
Usp14
/ MEFs displayed weak phosphorylation of endogenous
Dvl2 and LRP6 proteins upon Wnt3a CM treatment (Figure 5a). In
wild-type MEFs, both Dvl2 and LRP6 became prominently
phosphorylated at B1 to 2h following Wnt3a CM treatment,
overlapping with the peak period of Dvl-Usp14 interaction
(Figure 3b). Similar to the effect of Usp14 knockout, wild-type
MEFs treated with IU1 showed signiﬁcantly reduced LRP6
phosphorylation (Figure 5b). Consistent with these ﬁndings, the
Wnt3a CM-induced expression of Wnt target genes, such as Nkd1
and Lef1, was signiﬁcantly impaired in Usp14
/ MEFs or wild-
type MEFs treated with IU1 (Figure 5c). To further conﬁrm that
Usp14 is important for Wnt pathway function, an axis duplication
assay using Xenopus embryos was performed. Consistent with the
data obtained using cell culture systems, ectopic expression of WT
Usp14 enhanced, whereas Usp14-CA inhibited, Dvl2-induced axis
duplication (Figure 5d). Overall, these results suggest that Usp14
has a positive role in the regulation of Wnt/b-catenin signaling. In
addition, the delayed phosphorylation of Dvl2 in Usp14
/ MEFs
upon Wnt5a CM treatment may indicate that regulation of Dvl
polyubiquitination is implicated in non-canonical Wnt signaling
pathways as well (Supplementary Figure S5a).
As a lack of Dvl deubiquitination by Usp14 appears to attenuate
Wnt signaling, we proposed that an elevated forward rate of
ubiquitination, which will be counteracted by Usp14 activity,
might be induced by Wnt3a CM treatment. We could observe only
modestly increased polyubiquitinated Dvl after 2h Wnt3a CM
treatment, perhaps due to active ubiquitination and deubiquitina-
tion during this time period (Figure 5e). In contrast, transient
expression of inactive Usp14-CA dramatically increased the levels
of polyubiquitinated Dvl2 (Supplementary Figure S5b). The
enhanced ubiquitination in the presence of Usp14-CA was
detected within 30min after treatment of Wnt3a CM and steadily
increased with time (Figure 5e). In summary, our data strongly
suggest that Usp14-mediated deubiquitination is necessary for
productive signaling upon Wnt3a CM treatment.
Usp14 levels are strongly correlated with b-catenin in human
colon cancer
Abnormal activation of the Wnt signaling pathway is known to be
linked to the initiation of most colorectal cancers.
29 As Usp14
appeared to be a positive regulator of the Wnt signaling pathway,
we hypothesized that an elevated level of Usp14 may potentiate
b-catenin-mediated colon cancer development. To test this
hypothesis, we ﬁrst examined Usp14 levels in well-characterized
colorectal carcinoma cell lines and compared them with those of
other immortalized cell lines (Figure 6a). SW480 and LOVO colon
cancer cells exhibited signiﬁcantly increased levels of Usp14 in
comparison with wild-type MEFs, HEK293 cells and other cancer
cell lines derived from prostate (DU145), ovarian (HeLa) and breast
cancer (MCF-7), whereas a7, a subunit of the 26S proteasome, was
not increased. DLD1 and Caco2 showed modestly increased or at
least similar levels of Usp14 as control cells, whereas HCT116 cells
displayed low Usp14 expression. We next examined the level of
Usp14 in human colon cancer tissues. Three colon cancer tissues
were initially obtained from three individual colon cancer patients,
and each colon tissue was divided into normal (N) or tumorous (T)
tissues based on histological analysis. All pairs (N/T) from same
individuals showed signiﬁcantly increased Usp14 levels in
cancerous colon tissues compared with normal counterparts
(Figure 6b). We also observed upregulated Usp14 mRNA levels in
the colon cancer tissues (Supplementary Figure S6).
To further test the correlation between Usp14 and b-catenin in
colorectal cancer, we performed a tissue microarray using 122
colorectal carcinoma and control tissues. In immunohistochemical
analysis, weak Usp14 immunoreactivity was observed in the
cytoplasm of corresponding normal colorectal mucosal cells
(Figure 6c), and surrounding stromal cells such as ﬁbroblasts
were negative for Usp14 immunostaining. Signiﬁcantly over-
expressed Usp14 was detected in 71 (58.2%) of 122 colorectal
carcinomas (Figure 6c and Supplementary Table S1). Tumor
tissues, even different portions of the same tumor, showed similar
expression levels of Usp14, and therefore, no evidence of
intratumoral heterogeneity (data not shown). Based on Duke’s
stage classiﬁcation, Usp14 overexpression was categorized into
different stages: 8 of 12 cases corresponding to stage A (66.7%), 26
of 47 to stage B (55.3%), 32 of 55 to stage C (58.2%), and 5 of 8 to
stage D (62.5%) (Supplementary Table S1). In addition, Usp14
protein was overexpressed in 37 of 61 cases with lymph node
metastasis (60.7%). Statistically, there was no relationship between
altered Usp14 expression and clinicopathological parameters,
including clinical stage (Bartholomew’s test, P40.05) and lymph
node metastasis (w
2 test, P40.05). However, altered Usp14 levels
were closely associated with b-catenin expression in colorectal
cancer tissues (Po0.0001) (Supplementary Table S1). This correla-
tion was much stronger than that between Pin1, colon c
ancer marker and b-catenin.
30 Overall, these data suggest that
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Oncogenesis (2013), 1–11 & 2013 Macmillan Publishers LimitedFigure 4. Ubiquitination of K444 and K451 is regulated by Usp14. (a) Isolation of ubiquitinated forms of myc-Dvl-DRDU. Plasmids expressing
myc-Dvl-DRDU and Flag-Ub (K48R) were co-transfected into HEK293T cells. Dvl was enriched by two-step immunoprecipitation, followed by
SDS–PAGE/Coomassie Brilliant Blue staining. Gel slices marked (I) and (II) were excised for ESI-MS analysis as described under ‘Materials and
methods’. (b) K444 and K451 are ubiquitinated in myc-Dvl-DRDU by ESI-MS analysis. Schematic diagram for the candidate ubiquitination sites
identiﬁed in this analysis (top). ESI-MS spectra for ubiquitinated Dvl on K444 and K451 are presented. (c) Ubiquitination of Dvl-DRDU is
reduced by the DEP4KR mutations. Dvls (WT, DRDU and DRDU-DEP4KR) were co-transfected with Flag-Ub-K48R into HEK293T cells. Protein
samples were analyzed by immunoprecipitation/immunoblotting as indicated. (d) Usp14 knockdown inhibits reporter activity induced by
WT-Dvl but not that induced by Dvl-DEP4KR. (e) Dvl-DEP4KR, but not Dvl-VK2, interacted with Fzd5 as wild-type Dvl. Dvls (WT, VK2 and
DEP4KR) were co-transfected with or without HA-Fzd5 into HEK293T cells. Protein samples were analyzed by immunoprecipitation/
immunoblotting as indicated.
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& 2013 Macmillan Publishers Limited Oncogenesis (2013), 1–11Figure 5. Inhibition of Usp14 delays Wnt signal transduction. (a) Phosphorylation of Dvl2 and LRP6 in response to Wnt is delayed in Usp14
/
MEFs. Wild-type and Usp14
/ MEFs were treated with Wnt3a CM for various times as indicated. Protein samples were collected and analyzed
by SDS–PAGE/immunoblotting. Anti-pLRP6 antibodies recognize phospho-Ser1490 of LRP6. (b) Inhibition of Usp14 by IU1 delays Wnt3a-
mediated phosphorylation of LRP6. HEK293T cells were treated with IU1 for 4h and subsequently incubated in Wnt3a CM containing IU1 for
various times as indicated. Protein samples were collected and analyzed by SDS–PAGE/immunoblotting. (c) A null mutation in Usp14
attenuates expression of Wnt target genes, Nkd1 (left) and Lef1 (right). Wild-type and Usp14
/ MEFs, and IU1-treated or -untreated wild-type
MEF cells were incubated with Wnt3a CM for 6h before collection of mRNA. Relative mRNA levels of Lef1 and Nkd1 in cells were measured by
standard qPCR methods (* indicates Po0.0006). (d) Axis duplication was assessed in Xenopus tadpole embryo. mRNAs for GFP-xDvl2 (500pg),
Usp14 (250pg), Usp14-CA (250pg), and Usp14DUBL (250pg) were injected as indicated. Each number of analyzed embryos (n) is indicated.
(e) Treatment with Wnt3a induced the level of polyubiquitinated Dvl2 in HEK293T cells when deubiquitination was blocked by ectopic
expression of Usp14-CA. Flag-tagged K48R ubiquitin was co-transfected with empty or Usp14-CA constructs in HEK293T cells, followed by
treatment with Wnt3a-conditioned media for indicated time periods and immunoprecipitation/immunoblotting to detect polyubiquitinated
Dvl2.
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Oncogenesis (2013), 1–11 & 2013 Macmillan Publishers Limitedincreased expression of Usp14 may enhance b-catenin-mediated
transformation of normal colon cells, but not metastasis of
malignant colon cancer cells.
DISCUSSION
We report here a novel signaling mechanism in the Wnt pathway,
involving K63-linked polyubiquitination of Dvl. These ubiquitin
chains are induced by Wnt conditioned medium and
rapidly disassembled by a speciﬁc DUB, Usp14. Dvl was found to
interact with Usp14 in a Wnt-dependent manner to promote rapid
disassembly of Dvl-bound, K63-linked chains. Contrary to
its established mechanistic role, Usp14 mediates deubiquitination
of Dvl without a requirement for its UBL domain. Because the UBL
domain of Usp14 is critical for its association with the proteasome,
it is likely that free Usp14 is competent to disassemble K63 chains
bound to Dvl. Lack of deubiquitination by Usp14 prevented
activation of Wnt/b-catenin signaling, based on Dvl and
LRP6 phosphorylation, reporter activities, as well as a Xenopus
embryonic axis duplication assay, suggesting that Usp14 has a
positive role in Wnt/b-catenin signaling. Consistently, the level of
Usp14 was strongly correlated with the level of b-catenin in
human colorectal cancer.
Based on these observations, we propose a model wherein
Usp14-mediated deubiquitination of Dvl regulates the progression
of downstream Wnt signaling upon external stimulation
by Wnt (Figure 7). Active K63-linked ubiquitination of Dvl occurred
with Wnt treatment and did not result in proteasomal degradation
(Figure 5e and Supplementary Figure S5b). Therefore, we
reasoned that the interaction between the RDU and K63-linked
polyubiquitin of Dvl may produce a conformation necessary for
interaction with Usp14 (Figure 7). Usp14 deubiquitinates
K63-linked polyubiquitin and dissociates from Dvl, which is
subsequently phosphorylated in response to Wnt. Properly
phosphorylated Dvl then functions as an activator of Wnt
signaling. However, deletion of the RDU or mutation of residues
that participate in the interaction with polyubiquitin may prevent
the conformational change necessary for interaction with Usp14.
This could lead to increased Dvl ubiquitination levels as well as
reduced phosphorylation. Similarly, knockdown of Usp14 results in
increased ubiquitination of Dvl and reduced phosphorylation of
Dvl, thereby preventing the activation of downstream Wnt/b-
catenin signaling. Therefore, Usp14 functions as a novel regulator
of the Wnt signaling pathway.
Consistent with our model, the level of Usp14 was elevated in
human colorectal cancer tissues displaying high levels of b-catenin
(Supplementary Table S1). The mechanistic cause of this elevation
is yet to be determined and it needs to be determined whether
increased Usp14 mRNA expression promotes or simply accom-
panies the progression of colon cancer. However, it is clear that
increased Usp14 reinforces b-catenin-mediated Wnt signaling,
which may enhance the onset of cancer formation.
Usp14
rrk114/rrk114 (considered as Usp14
/ in our manuscript)
mice display a male-speciﬁc sterility defect as well as a neurologic
phenotype culminating in widespread paralysis and premature
death (Crimmins, 2009) #228,. As Usp14
rrk114/rrk114 is not Usp14-null
mice and the knockout phenotypes of different Wnts are so
diverse (See Wnt home page, http://www.stanford.edu/group/
nusselab/cgi-bin/wnt/), it is difﬁcult to identify obvious similarity
between Usp14
/ and Wnt knockout mice phenotypes. In
addition, the fact that Usp14
/ MEFs showed delayed Wnt signal
transduction (Figures 5a and b), rather than complete blocking,
suggests that there are certain functional redundancies shared by
other deubiquitinase(s).
Figure 6. Level of Usp14 is strongly correlated with expression of b-catenin in human colorectal cancer. (a) Endogenous Usp14 levels in
colorectal carcinoma and other immortalized cell lines. Each lane was loaded with 20mg of whole-cell extract. Wild-type and Usp14
/ MEFs
were compared as positive and negative controls of Usp14 signaling, respectively. b-actin and a7 were used as loading controls.
(b) Comparison of Usp14 protein levels in normal (N) and tumorous (T) human colon tissues. Each pair was derived from an individual colon
cancer patient. (c) Immunohistological analysis of Usp14 in colorectal cancer tissue microarray. (a) Immunoreactivity for Usp14 was weak in the
cytoplasm of normal colonic mucosal epithelial cells. (b) Colon cancer cells exhibited moderate and strong Usp14 signals in moderately
differentiated cancer. (c) Negative Usp14 staining in colon cancer. See Supplementary Table S1 for tissue microarray results from 122 colorectal
cancer tissues.
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Dvl are known, whereas the E3 ligase that controls K63-linked
ubiquitination has not been identiﬁed. Gao et al.
14 showed that
von Hippel–Lindau induces polyubiquitination of Dvl, which in
turn leads to autophagosomal degradation.
14 As they show that
p62, which is known to prefer K63-linked polyubiquitinated
substrates,
31,32 recognizes ubiquitinated Dvl for autophagic
degradation, von Hippel–Lindau may catalyze K63-linked poly-
ubiquitination of Dvl. Identiﬁcation of the E3 ligase for K63-linked
polyubiquitination of Dvl in Wnt signaling will be of interest, as it
may be a useful therapeutic target for diseases caused by
misregulation of Wnt signaling.
Here, we reveal a novel role and regulatory mechanism
for Usp14. It has been shown that Usp14 is involved in the
processing of polyubiquitinated substrates bearing either pure
K63 chains or mixed linkage types in a manner that depends
on proteasome association.
24 However, our data suggest that
Usp14 deubiquitinates K63-linked polyubiquitin chains in vivo
and in vitro without association with proteasome (Figure 2
and Supplementary Figure S2b). We propose that an unknown
modiﬁcation of Usp14 in the context of Wnt signaling and speciﬁc
conformation of Dvl caused by K63-linked ubiquitination, permit
Usp14 to interact with Dvl and have deubiquitinase activity
without association of proteasome. This hypothesis may explain
why no Usp14-interacting partners other than the proteasome
have been identiﬁed. Examination of the nature of Usp14
modiﬁcation in the presence of Wnt and identiﬁcation of enzymes
responsible for the modiﬁcation will provide a framework for the
study of inducible regulation of Usp14.
High expression levels of Usp14 in colorectal cancer (18 of 99
(18.9%)) have been shown to be associated with liver and lymph
node metastasis.
33 Our data from tissue microarray indicated that
a much higher proportion of colorectal carcinomas have high
levels of Usp14 (71 of 122 (58.2%)) (Figure 6c and Supplementary
Table S1). More signiﬁcantly, most colorectal carcinomas that had
a high level of Usp14 also showed a high level of b-catenin (63 of
71 (88.7%)). We suggest that Usp14 enhances the responsiveness
to external Wnt signal, thus increasing the b-catenin level, which
then serves as an initial hit for the oncogenic transformation
of colorectal cells. Therefore, it will be interesting to examine
whether the level of Usp14 can be used as a prognostic marker
and therapeutic target for other Wnt-dependent types of cancer.
MATERIALS AND METHODS
All material and methods are described in Supplementary Information.
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